HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janet L Anderl Selected Research

Janet L Anderl Research Topics

Disease

4Neoplasms (Cancer)
11/2017 - 05/2014
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 01/2021
2Rheumatoid Arthritis
01/2023 - 01/2021
2Autoimmune Diseases (Autoimmune Disease)
04/2017 - 01/2013
2Multiple Myeloma
12/2014 - 05/2011
2Hematologic Neoplasms (Hematological Malignancy)
07/2014 - 05/2014
2Leukemia
07/2014 - 05/2014
1Lupus Nephritis
01/2023
1Proteinuria
01/2023
1Rheumatic Diseases (Rheumatism)
12/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2014
1Lung Neoplasms (Lung Cancer)
12/2014
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2014
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2014
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2013
1Peripheral Nervous System Diseases (PNS Diseases)
05/2011

Drug/Important Bio-Agent (IBA)

5Bortezomib (Velcade)FDA Link
04/2017 - 05/2011
3KZR-616IBA
01/2023 - 12/2018
3Proteasome InhibitorsIBA
12/2014 - 01/2013
3Proteasome Endopeptidase Complex (Proteasome)IBA
12/2014 - 05/2011
2CytokinesIBA
01/2023 - 11/2017
2carfilzomibIBA
04/2017 - 12/2014
1Histocompatibility Antigens Class IIBA
11/2017
1Cisplatin (Platino)FDA LinkGeneric
12/2014
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2014
1Caspase 3 (Caspase-3)IBA
12/2014
1marizomibIBA
07/2014
1antineoplaston A10 (A 10)IBA
05/2014
1Rituximab (Mabthera)FDA Link
01/2013
1DipeptidesIBA
05/2011